特素(紫杉醇)治疗晚期恶性肿瘤的临床研究
A Study on Taxol in Advanced Malignant Tumors
-
摘要: 目的:分析特素治疗31例晚期恶性肿瘤效果。方法:患者接受以特素为主的联合化疗,并给患者标准的抗过敏反应用药。结果:特素治疗疗效为70.96%,主要毒性为骨髓抑制,未发生任何因特素毒性过敏死亡病例。结论:特素对晚期恶性肿瘤的疗效肯定,是目前治疗晚期恶性肿瘤的良好药物。Abstract: objective:Purpose 31cases of advanced malignant tumor treated by Paclitaxel are reported. Methods :The patients received Taxol containing combination chemotherapy,And standardised anti allergic durgs are used to patient. Results :Good effects of paclitaxel treatment showed 70 96%,Myelosuppresion is the principal toxicity,None case was died of durg allergy.conclusion:Taxol is a drug of choice in the treatment of advanced malignant tumors who are resistant to conventional chemotherapy.